Conférence et séminaire Oncologie

Digital DDR, ATR & PARP Inhibitors Summit 2022

Réf: 33422 25/01/2022 -> 27/01/2022 - En ligne

  The 5th Digital DDR, ATR & PARP Inhibitors Summit is coming at a timely inflection point within this field. With Wee1 & ATR approvals on the horizon and countless novel targets currently undergoing exciting pre-clinical validation, this unique & highly anticipated meeting ...

2nd TGF-β for Immuno-Oncology Drug Development Summit

Réf: 33423 25/01/2022 -> 27/01/2022 - En ligne

  From Cell Signaling to the Tumor Microenvironment, Exploit TGF-β’s Role in IO to Harness a Clinically Relevant, Safe & Efficacious Therapeutics   It is clear the world of TGF-β contains vast potential and excitement, in the past year alone we have seen great advances, ...

Transcription Factor-Directed Therapies Summit

Réf: 33534 08/03/2022 -> 10/03/2022 - Boston ^US

Accelerating the Advancement of Small Molecule Inhibitors, PROTAC-Based Degraders and Other Therapeutic Approaches Directed Towards Transcription Factors.

Immuno-Oncology 360°

Réf: 33574 16/03/2022 -> 18/03/2022 - Brooklyn ^US

IO360˚ convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

Mayo Clinic Gastrointestinal Cancers 2022

Réf: 33577 18/03/2022 -> 19/03/2022 - Coronado ^US

This course focuses on the treatment of gastrointestinal (GI) cancers, including esophageal, gastric, hepatocellular, pancreatic, small bowel, bile duct, anal and colorectal, and gallbladder.

2nd International Conference on Cancer Science and Research

Réf: 33433 24/03/2022 -> 25/03/2022 - London ^GB

Cancer Research Strengthening to fight against Cancer

International E-Conference on Women Health, Obstetrics and Gynecology

Réf: 33473 11/04/2022 -> 12/04/2022 - En ligne

Empowering and Creating a Healthier Future for Women

4th Allogeneic Cell Therapies Summit

Réf: 33592 09/05/2022 -> 12/05/2022 - Boston ^US

  The development of allogeneic cell therapies continues to gain momentum, with 293 allogeneic clinical trials ongoing worldwide, treating a wide range of indications! * They show blockbuster potential rivalling the autologous approach with improved accessibility, cost efficiency, and ...

Adenosine-Pathway Targeted Cancer Immunotherapy

Réf: 33568 10/05/2022 -> 12/05/2022 - Boston ^US

Overcoming Immunosuppression in the Tumor Microenvironment, Quantifying Adenosine Signatures to Identify Patient Responders and Optimizing Combinations to Enhance Treatment Potency

3rd International Pharmaceutical Conference and Expo

Réf: 33389 14/07/2022 -> 15/07/2022 - London ^GB

In the pharmaceuticals sector, bridging the gap between academia and industry.

54th Congress of the International Society of Paediatric Oncology - SIOP 2022

Réf: 33578 28/09/2022 -> 01/10/2022 - Barcelona ^ES

  The 54th Annual SIOP Congress will take place in Barcelona, Spain, from September 28-October 1, 2022.   The SIOP 2022 Congress will be the place to hear the latest research findings in the field and to catalyse new ideas, generated by the multi-disciplinary attendance for which ...

2nd International Women Health and Breast Cancer Conference

Réf: 33546 29/09/2022 -> 30/09/2022 - London ^GB

The 2nd International Women Health and Breast Cancer Conference welcomes you to meet healthcare experts in London on September 29-30, 2022.

Affordable Brachytherapy for Prostate Cancer in India

Réf: 31561 17/02/2020 -> 16/02/2023 - En ligne

Brachytherapy in India with Indian med guru is one of the best cancer treatment options at an affordable cost.

Mayo Clinic Radiation Oncology: Current Practice and Future Direction

Réf: 32970 17/01/2022 -> 21/01/2022 - Lahaina ^US

Mayo Clinic Radiation Oncology: Current Practice and Future Direction is intended to provide balanced and multidisciplinary discussion of contemporary cancer treatment.